City Pedia Web Search

Search results

1. Results From The WOW.Com Content Network

2. Subway Surfers - Wikipedia

   en.wikipedia.org/wiki/Subway_Surfers

   Subway Surfers[ a] is a 2012 endless runner mobile game which is co-developed by Kiloo and SYBO Games, private companies based in Denmark. It is available on Android, iOS, HarmonyOS, Amazon Fire Tablet, and Windows Phone platforms and uses the Unity game engine. [ 2] In the game, players take the role of young graffiti artists, led by Jake who ...

3. Temple Run 2 - Wikipedia

   en.wikipedia.org/wiki/Temple_Run_2

   Temple Run 2 is an endless runner video game developed and published by Imangi Studios. A sequel to Temple Run, the game was produced, designed and programmed by husband and wife team Keith Shepherd and Natalia Luckyanova, [ 7] with art by Kiril Tchangov. [ 7] It was released on the App Store on January 16, 2013, [ 1] on Google Play on January ...

4. Dinosaur Game - Wikipedia

   en.wikipedia.org/wiki/Dinosaur_Game

   Dinosaur Game. The Dinosaur Game[ 1] (also known as the Chrome Dino) [ 2] is a browser game developed by Google and built into the Google Chrome web browser. The player guides a pixelated t-rex across a side-scrolling landscape, avoiding obstacles to achieve a higher score. The game was created by members of the Chrome UX team in 2014.

5. Free Online Games: Play board games, card games, casino games ...

   www.aol.com/games

   Discover the best free online games at AOL.com - Play board, card, casino, puzzle and many more online games while chatting with others in real-time.

6. Sen. Bob Menendez's lawyer cites patriotism as a reason to ...

   www.aol.com/news/sen-bob-menendezs-lawyer-tells...

   July 10, 2024 at 6:38 PM. NEW YORK (AP) — Sen. Bob Menendez's lawyer cited patriotism as a reason to acquit his client Wednesday, telling a federal jury that it would be a “win for this ...

7. Patients push back against Novo Nordisk move to scrap an ...

   www.aol.com/news/patients-push-back-against-novo...

   LONDON/WASHINGTON (Reuters) - Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients ...